相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Anna He et al.
LANCET NEUROLOGY (2020)
Differential multiple sclerosis treatment allocation between Australia and New Zealand associated with clinical outcomes but not mood or quality of life
Aung Zaw Zaw Phyo et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study
Stephan Schmidt et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
J. William L. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Vitamin D for the treatment of multiple sclerosis: a meta-analysis
Laurie McLaughlin et al.
JOURNAL OF NEUROLOGY (2018)
Disease-modifying therapies for multiple sclerosis
Floriana De Angelis et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Importance of early treatment initiation in the clinical course of multiple sclerosis
Andrius Kavaliunas et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Importance of early treatment initiation in the clinical course of multiple sclerosis
Andrius Kavaliunas et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Treatment decisions in multiple sclerosis - insights from real-world observational studies
Maria Trojano et al.
NATURE REVIEWS NEUROLOGY (2017)
Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: A systematic review
Bernd Merkel et al.
AUTOIMMUNITY REVIEWS (2017)
Predictors of Long-Term Disability Accrual in Relapse-Onset Multiple Sclerosis
Vilija G. Jokubaitis et al.
ANNALS OF NEUROLOGY (2016)
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis
Alessio Signori et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis
Emer Fogarty et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator
Jacqueline Palace et al.
LANCET NEUROLOGY (2015)
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Daniel M. Hartung et al.
NEUROLOGY (2015)
Can we measure long-term treatment effects in multiple sclerosis?
Maria Pia Sormani et al.
NATURE REVIEWS NEUROLOGY (2015)
A Review of the Psychometric Properties of Generic Utility Measures in Multiple Sclerosis
Ayse Kuspinar et al.
PHARMACOECONOMICS (2014)
Interferon-beta and disability progression in relapsing-remitting multiple sclerosis
Jelena Drulovic et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2013)
Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis
Sara Leddy et al.
JOURNAL OF NEUROLOGY (2013)
Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale
Y. C. Learmonth et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Quality of life in patients with multiple sclerosis: the impact of depression, fatigue, and disability
Altlnay Goksel Karatepe et al.
INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH (2011)
MS prevalence in New Zealand, an ethnically and latitudinally diverse country
Bruce V. Taylor et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Real-Life Impact of Early Interferonβ Therapy in Relapsing Multiple Sclerosis
M. Trojano et al.
ANNALS OF NEUROLOGY (2009)
New Effect Size Rules of Thumb
Shlomo S. Sawilowsky
JOURNAL OF MODERN APPLIED STATISTICAL METHODS (2009)
Multiple sclerosis severity score -: Using disability and disease duration to rate disease severity
RHSR Roxburgh et al.
NEUROLOGY (2005)
International physical activity questionnaire:: 12-country reliability and validity
CL Craig et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2003)
Use of pharmacoeconomics information - Report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making
M Drummond et al.
VALUE IN HEALTH (2003)
分享论文
